Main competitors
Dividend Yield (N) Dividend Yield (N+1) P/E (N) Price to Book (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Capi.($)
- - -0.27x - -0.11x0.06x0.06x 35.76L
0.75%0.83%37.3x27.34x12.31x28.09x30.22x 71TCr
3.34%3.44%15.04x5.05x4.2x11.56x12.84x 38TCr
3.42%3.57%27.26x48.13x6.59x13.78x14.23x 34TCr
3%3.5%16.85x9.51x6.08x12.14x13.41x 31TCr
3.84%3.94%14.15x5.39x3.48x8.6x9.87x 26TCr
3.26%3.41%17.15x5.1x4.63x11.21x12.22x 24TCr
2.28%2.39%22.3x4.85x4.15x12.2x12.93x 22TCr
3.86%4.05%10.68x3.77x3.46x7.48x8.34x 21TCr
3.25%3.41%22.58x18.07x5.78x11.22x13.13x 16TCr
6.66%6.8%11.96x1.61x2.95x7.29x8.47x 15TCr
2.96%3.1%20.14x6.09x5.15x9.43x11.35x 14TCr
-.--%-.--%31.18x6.09x9.28x19.53x20.52x 12TCr
4.91%5.14%11.69x1.29x2.42x7.94x8.67x 12TCr
5.29%5.47%10.66x4.57x2.78x7.43x7.89x 9.54TCr
4.61%4.9%9.9x3.85x2.2x6.5x7.46x 7.69TCr
3.69%1.73%25.81x5.62x8.57x16.87x17.64x 7.64TCr
0.41%0.47%49.83x6.79x11x40.26x43.95x 5.3TCr
4.57%4.66%28.12x1.01x2.34x8.64x21.78x 4.69TCr
Average 3.34% 3.38% 20.12x 9.12x 5.12x 12.64x 14.47x 19.4TCr
Weighted average by Cap. 2.93% 3.04% 22.35x 13.96x 6.32x 14.74x 16.20x
Other Pharmaceuticals